Literature DB >> 35922692

Immunopotential of Pasteurella multocida bivalent outer membrane protein-based vaccine entrapped in aluminum hydroxide nanoparticles.

Haladhar Pegu1, Shantanu Tamuly2, Rajeev Kumar Sharma3, Probodh Borah1, Rita Nath4.   

Abstract

Swine pasteurellosis is one of the most economically important diseases of pig caused by Pasteurella multocida (P. multocida) capsular types A and D. These organisms are commensals and opportunistic pathogens in the upper respiratory tract in pig. In the present study, we extracted whole outer membrane proteins (OMP) from P. multocida capsular types A and D and were mixed together in the ratio of 1:1 forming bivalent outer-membrane proteins. The bivalent OMP was adsorbed onto aluminum hydroxide nanoparticles. The size of aluminum hydroxide nanoparticles adsorbed outer membrane protein was found to be in the range of 125 to 130 nm. We observed that aluminum hydroxide nanoparticles adjuvanted bivalent OMP-based vaccine elicited quicker immune kinetics in terms of IgG response as compared to aluminum hydroxide microparticles adjuvanted bivalent bacterin vaccine against P. multocida capsular type A and D.
© 2022. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.

Entities:  

Keywords:  Aluminum hydroxide; Nanoparticles; Outer membrane protein (OMP); Pasteurella multocida; Vaccine

Year:  2022        PMID: 35922692     DOI: 10.1007/s42770-022-00795-1

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.214


  10 in total

1.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

2.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

3.  Detection of Pasteurella multocida isolates from local pigs of India by polymerase chain reaction and their antibiogram.

Authors:  Swaraj Rajkhowa; Ingudam Shakuntala; Seema Rani Pegu; Rajib Kumar Das; Anubrata Das
Journal:  Trop Anim Health Prod       Date:  2012-02-09       Impact factor: 1.559

4.  Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system.

Authors:  K M Townsend; J D Boyce; J Y Chung; A J Frost; B Adler
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Antibodies to outer membrane proteins but not to lipopolysaccharide inhibit pulmonary proliferation of Pasteurella multocida in mice.

Authors:  Y S Lu; H N Aguila; W C Lai; S P Pakes
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Calcium phosphate nanoparticle adjuvant.

Authors:  Q He; A R Mitchell; S L Johnson; C Wagner-Bartak; T Morcol; S J Bell
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

7.  Immunogenicity of outer membrane protein of Pasteurella multocida in buffalo calves.

Authors:  U S Pati; S K Srivastava; S C Roy; T More
Journal:  Vet Microbiol       Date:  1996-10       Impact factor: 3.293

8.  Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2.

Authors:  Qing He; Alaina Mitchell; Tulin Morcol; Steve J D Bell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Relationship between the iron regulated outer membrane proteins and the outer membrane proteins of in vivo grown Pasteurella multocida.

Authors:  K Choi-Kim; S K Maheswaran; L J Felice; T W Molitor
Journal:  Vet Microbiol       Date:  1991-06       Impact factor: 3.293

Review 10.  Aluminium compounds for use in vaccines.

Authors:  Erik B Lindblad
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.